Gene · 642
Papers2,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States. | AIDS Res Ther | 2022 | 35216610 | PubTator, text mining | PubMed |
| Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses. | Cancers (Basel) | 2022 | 35205744 | PubTator, text mining | PubMed |
| Phosphoproteomic Analysis of Breast Cancer-Derived Small Extracellular Vesicles Reveals Disease-Specific Phosphorylated Enzymes. | Biomedicines | 2022 | 35203617 | PubTator, text mining | PubMed |
| Comprehensive Statistical and Bioinformatics Analysis in the Deciphering of Putative Mechanisms by Which Lipid-Associated GWAS Loci Contribute to Coronary Artery Disease. | Biomedicines | 2022 | 35203469 | PubTator, text mining | PubMed |
| Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy. | Toxins (Basel) | 2022 | 35202166 | PubTator, text mining | PubMed |
| [Positioning the hand to act-Validation of the 8-point reaching range test]. | Z Gerontol Geriatr | 2022 | 35201394 | PubTator, text mining | PubMed |
| NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. | Proc Natl Acad Sci U S A | 2022 | 35197278 | PubTator, text mining | PubMed |
| Understanding disease symptoms and impacts and producing qualitatively-derived severity stages for MPS IIIA: a mixed methods approach. | Orphanet J Rare Dis | 2022 | 35193633 | PubTator, text mining | PubMed |
| Full endoscopic versus open discectomy for sciatica: randomised controlled non-inferiority trial. | BMJ | 2022 | 35190388 | PubTator, text mining | PubMed |
| Low-calorie sweeteners and health outcomes: an evaluation of rapid versus traditional evidence mapping. | BMC Res Notes | 2022 | 35183236 | PubTator, text mining | PubMed |
| Molecular basis of force-pCa relation in MYL2 cardiomyopathy mice: Role of the super-relaxed state of myosin. | Proc Natl Acad Sci U S A | 2022 | 35177471 | PubTator, text mining | PubMed |
| Overexpressed CMTM6 Improves Prognosis and Associated With Immune Infiltrates of Ovarian Cancer. | Front Mol Biosci | 2022 | 35174213 | PubTator, text mining | PubMed |
| Brain Antigens Stimulate Proliferation of T Lymphocytes With a Pathogenic Phenotype in Multiple Sclerosis Patients. | Front Immunol | 2022 | 35173742 | PubTator, text mining | PubMed |
| Evolutionary Analysis of Dipeptidyl Peptidase I. | Int J Mol Sci | 2022 | 35163774 | PubTator, text mining | PubMed |
| The Discovery and Function of Filaggrin. | Int J Mol Sci | 2022 | 35163390 | PubTator, text mining | PubMed |
| Cardiovascular Biomarker Profiles in Obesity and Relation to Normalization of Subclinical Cardiac Dysfunction after Bariatric Surgery. | Cells | 2022 | 35159232 | PubTator, text mining | PubMed |
| Demographic, Virological Characteristics and Prognosis of Asymptomatic COVID-19 Patients in South China. | Front Med (Lausanne) | 2022 | 35155505 | PubTator, text mining | PubMed |
| The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis. | Front Pharmacol | 2022 | 35153773 | PubTator, text mining | PubMed |
| A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant. | EMBO Mol Med | 2022 | 35138028 | PubTator, text mining | PubMed |
| The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells. | J Clin Invest | 2022 | 35133986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/642/papers?page=36